BASALOG (Insulin Glargine (100IU/ml))

Basalog 100IU/ml Injection is a long-acting insulin formulation utilized for managing type 1 and type 2 diabetes mellitus in both adults and pediatric patients. This medication maintains a consistent insulin level throughout the day, aiding in the regulation of blood glucose levels. Such control is crucial for preventing diabetes-related complications. Basalog can be administered as a standalone treatment or in conjunction with rapid-acting insulins or additional antidiabetic medications. It is essential for patients to receive proper instruction from healthcare professionals on the correct subcutaneous injection technique. Adhering to the prescribed dosage is vital for achieving optimal therapeutic outcomes. Discontinuation of this medication may lead to significantly elevated blood sugar levels, increasing the risk of severe complications. It is important to note that Basalog is just one component of a comprehensive diabetes management plan, which should also include a balanced diet, regular physical activity, and weight management as advised by a healthcare provider. The primary adverse effect associated with Basalog is the risk of hypoglycemia, which can be mitigated by administering the correct dosages, maintaining regular meal times, and consistently monitoring blood glucose levels. Excessive alcohol intake may also contribute to lowered blood sugar. Other potential side effects include swelling in the extremities, skin reactions at the injection site, allergic responses, itching, rashes, and potential weight gain.